Patents by Inventor Michael Kron

Michael Kron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8286875
    Abstract: An apparatus for commercial transactions using a transaction card via a communication device in audio communication with a remote processor assembly is provided. The apparatus comprises an input device for capturing information from the transaction card, a controller for converting the captured card information into an audio signal. The controller is linked to the communication device. The apparatus may also be part of an assembly wherein this controller is part of the communication device. The remote processor assembly includes a transaction server linked to a remote processor/issuer for validating the transaction card data. A system including this apparatus, the communication device and the transaction server is also provided. Methods therefore are also disclosed.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: October 16, 2012
    Assignee: 4361423 Canada Inc.
    Inventors: Tai Kwan Jimmy Tang, Chi Wah Lo, Kenneth G. Mages, Michael Kron
  • Publication number: 20110290874
    Abstract: An apparatus for commercial transactions using a transaction card via a communication device in audio communication with a remote processor assembly is provided. The apparatus comprises an input device for capturing information from the transaction card, a controller for converting the captured card information into an audio signal. The controller is linked to the communication device. The apparatus may also be part of an assembly wherein this controller is part of the communication device. The remote processor assembly includes a transaction server linked to a remote processor/issuer for validating the transaction card data. A system including this apparatus, the communication device and the transaction server is also provided. Methods therefore are also disclosed.
    Type: Application
    Filed: June 16, 2011
    Publication date: December 1, 2011
    Applicant: HomeATM
    Inventors: TAI KWAN JIMMY TANG, Chi Wah Lo, Kenneth G. Mages, Michael Kron
  • Publication number: 20100060230
    Abstract: A mobile charger including a connector that facilitates charging at least one first battery from at least one second battery, wherein the second battery is a secondary battery and the second battery has a higher capacity than the first battery, thus allowing the first battery to be charged more than once; and a method for charging at least one first battery from at least one second battery, including connecting the second battery to the first battery with a secondary battery being used as the second battery to charge the at least one first battery, which secondary battery has a higher capacity than the first battery such that the first battery can be charged more than once.
    Type: Application
    Filed: August 2, 2006
    Publication date: March 11, 2010
    Applicant: VARTA MICROBATTERY GMBH, A CORPORATION OF GERMANY
    Inventors: Herbert Schein, Michael Kron, Dejan Ilic
  • Patent number: 7658937
    Abstract: A process for the preparation of hydroxyl substituted anthraquinones is described. The process couples a phthalic anhydride (substituted or unsubstituted) to benzene ring moiety substituted with at least two hydroxyl groups. Remaining hydroxy groups were converted to methoxy groups in some anthraquinones. The compounds are particularly useful for the treatment of parasitic diseases. Also, a method of treating or preventing malaria, filariasis schistosomiasis and other parasitic diseases using anthraquinones.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: February 9, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Muraleedharan G. Nair, Mugunthu R. Dhananjeyan, Michael A. Kron, Youli P. Milev
  • Publication number: 20070207992
    Abstract: The present invention relates to novel geldanamycin derivatives which have antitumor and antiparasitic properties. The geldanamycin derivatives disclosed herein have antitumor properties in humans due to their interaction with human heat shock protein 90 (hsp90). The human parasites Plasmodium falciparum, Trypanosoma Cruzi, and Leishmania donovani are lethally susceptible to exposure to geldanamycin via complexation of geldanamycin with their homologs (Pfhsp90, hsp83, and hsp90, respectively) of the human hsp90. The geldanamycin derivatives disclosed herein also interact with these parasitic hsp90 homologs so as to have antiparasitic properties.
    Type: Application
    Filed: February 20, 2007
    Publication date: September 6, 2007
    Applicant: Board of Trustees of Michigan State University
    Inventors: David Wenkert, Leslie Kuhn, Erica Scheller, Michael Kron, Yuehai Shen
  • Publication number: 20050267307
    Abstract: A process for the preparation of hydroxyl substituted anthraquinones is described. The process couples a phthalic anhydride (substituted or unsubstituted) to benzene ring moiety substituted with at least two hydroxyl groups. Remaining hydroxy groups were converted to methoxy groups in some anthraquinones. The compounds are particularly useful for the treatment of parasitic diseases. Also, a method of treating or preventing malaria, filariasis schistosomiasis and other parasitic diseases using anthraquinones.
    Type: Application
    Filed: March 7, 2005
    Publication date: December 1, 2005
    Applicant: Board of Trustees of Michigan State University
    Inventors: Muraleedharan Nair, Mugunthu Dhananjeyan, Michael Kron, Youli Milev
  • Patent number: 6245539
    Abstract: The CDNA sequence of human cytosolic asparaginyl-tRNA synthesis AsnRS, the bacterial expression of the recombinant enzyme and its activity assays with different sources of tRNA is described. The reactivity with a human autoimmune serum is described. The implication of the human cytoplasmic AsnRS in an autoimmune disorder is a property of this enzyme.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: June 12, 2001
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Michael A. Kron, Michael M. Hartlein, Michito Hirikata
  • Patent number: 5846771
    Abstract: Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: December 8, 1998
    Assignees: Board of Trustees operating Michigan State University, European Molecular Biology Laboratory
    Inventors: Michael A. Kron, Reuben Leberman
  • Patent number: 5721116
    Abstract: Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
    Type: Grant
    Filed: April 9, 1996
    Date of Patent: February 24, 1998
    Assignees: Board of Trustees operating Michigan State University, European Molecular Biology Laboratory
    Inventors: Michael A. Kron, Reuben Leberman
  • Patent number: 5695962
    Abstract: Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
    Type: Grant
    Filed: April 9, 1996
    Date of Patent: December 9, 1997
    Assignees: Board of Trustees operating Michigan State University, European Molecular Biology Laboratory
    Inventors: Michael A. Kron, Reuben Leberman
  • Patent number: 5561054
    Abstract: Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: October 1, 1996
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Michael A. Kron, Reuben Leberman